Nippon Chemiphar Co., Ltd.
2-2-3 Iwamoto-cho
Chiyoda-ku
Tokyo
101
Tel: 81-3-38631211
Fax: 81-3-38645940
6 articles about Nippon Chemiphar Co., Ltd.
-
Nippon Chemiphar Announces Progress on Its Hyperuricemia/Gout Projects; NC-2500 Shows Favorable Profile to Lower Serum Uric Acid in Phase-1 Study
11/29/2017
NC-2500 showed favorable urate-lowering properties which may make a difference in gout treatment.
-
Nippon Chemiphar Co., Ltd. And SOM Biotech To Cooperate On New, Orphan Disease Indications For Bevantolol (Calvan)
10/11/2017
-
Ranbaxy Laboratories Sells Stake in JV to its Partner Nippon Chemiphar Co., Ltd.
12/8/2009
-
Nippon Chemiphar Co., Ltd. And Torii Pharmaceutical Co. To Terminate Sales Tie-Up For Urinary Alkalizer
3/14/2006
-
Carrington Laboratories Subsidiary Announces Research Collaboration With Nippon Chemiphar Co., Ltd. To Evaluate Delivery System For Alzheimer's Drug Candidate
2/6/2006
-
Ranbaxy Laboratories Consolidates Relationship With Japan JV Partner Nippon Chemiphar Co., Ltd.
11/11/2005